Crossref
Real world data are needed to establish safety of adjuvant immune checkpoint inhibitors after pneumonectomy
AME Clinical Trials Review · 2023
DOI: 10.21037/actr-23-16 ↗Kurz gefasst
Fachartikel in der Zeitschrift AME Clinical Trials Review, 2023. Verfasst von Ikuo Sekine.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sekine, I. (2023). Real world data are needed to establish safety of adjuvant immune checkpoint inhibitors after pneumonectomy. AME Clinical Trials Review. https://doi.org/10.21037/actr-23-16
Vancouver
Sekine I. Real world data are needed to establish safety of adjuvant immune checkpoint inhibitors after pneumonectomy. AME Clinical Trials Review. 2023. doi:10.21037/actr-23-16
BibTeX
@article{Sekine2023,
author = {Sekine, Ikuo},
title = {Real world data are needed to establish safety of adjuvant immune checkpoint inhibitors after pneumonectomy},
journal = {AME Clinical Trials Review},
year = {2023},
doi = {10.21037/actr-23-16}
}
EUVIMED